• Glenmark is the only company to launch this product in India through an exclusive licensing agreement with Pharma Medico
• Nourkrin® Woman is a globally renowned, clinically-proven proteoglycan replacement formula that normalises hair growth cycle in women
• Nourkrin® Woman has proven to normalise hair growth cycle affected by various factors like stress, medical disorders, childbirth, pollution, use of styling products

Chennai, 16^th March 2018: Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced the launch of Nourkrin®Woman, a globally renowned, clinically-proven proteoglycan replacement formula, for normalizing hair growth cycle. Nourkrin® Woman will be exclusively marketed in India by Glenmark Pharmaceuticals under a licensing agreement with Denmark-headquartered firm Pharma Medico.

Nourkrin® is a proven formula, based on more than 56 scientific studies and is recognized by leading regulatory agencies globally. Nourkrin® is the number one product in UK and Europe for hair loss management and is available in more than 40 countries worldwide. Nourkrin® Woman contains Marilex®, a unique and proprietary scientific formula, rich in specific proteoglycans (PG) essential for hair follicle development, which helps in normalizing, supporting and maintaining the Hair Growth Cycle.

Sujesh Vasudevan, President and Head – India, Middle East and Africa, Glenmark Pharmaceuticals said, “Glenmark is proud to launch Nourkrin® Woman in India. Glenmark has been present in the field of Dermatology for over 4 decades bringing globally advanced therapies to Indian patients. The launch of Nourkrin® will enable millions of women in India manage hair loss not by just preventing hair loss but by normalizing the hair growth cycle and tackling the problem at the follicular level.”

Rajesh Kapur, Senior Vice President – Sales & Marketing, Glenmark Pharmaceuticals said, “It is alarming to note that 60% women experience hair loss at some stage in their lives and in India there are more than 90 million women reported to have hair loss. With male and female hair loss patterns being different, Nourkrin® Woman is the first and exclusive product focusing on female hair loss problem through proteoglycan replacement.”

Nourkrin® Woman is a core prescription product in India and will be promoted by Glenmark exclusively to dermatologists across the country. It will also be available at select retail chemists and healthcare portals.

According to Indian Journal of Clinical and Experimental Dermatology, 15.3% women in India reportedly suffer from hair loss which equates to about 90 million women reportedly suffering with hair loss problem.

Number of factors such as stress, pollution, certain medical disorders, childbirth, conditions caused by hormonal imbalances, use of certain drugs, nutritional deficiencies, and use of styling products disrupt the hair growth cycle and lead to hair loss in women. Nourkrin Woman addresses the core issue of normalizing the hair growth cycle.

Nourkrin® Woman, available as tablets, is an easy-to-use therapy compared to clinical procedures and hair sprays and creams. The tablets have to be consumed twice a day for six months.